TMCI logo

Treace Medical Concepts, Inc. Stock Price

NasdaqGS:TMCI Community·US$380.9m Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

TMCI Share Price Performance

US$5.88
0.62 (11.79%)
51.0% undervalued intrinsic discount
US$12.00
Fair Value
US$5.88
0.62 (11.79%)
51.0% undervalued intrinsic discount
US$12.00
Fair Value
Price US$5.88
AnalystHighTarget US$12.00
AnalystConsensusTarget US$8.58

TMCI Community Narratives

AnalystHighTarget·
Fair Value US$12 48.7% undervalued intrinsic discount

Aging Population And Obesity Will Transform Foot Surgery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$8.58 28.2% undervalued intrinsic discount

Minimally Invasive Bunion Solutions Will Broaden Market Penetration

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent TMCI News & Updates

Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Shares Leap 27% Yet They're Still Not Telling The Full Story

Aug 20
Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Shares Leap 27% Yet They're Still Not Telling The Full Story

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target

Aug 10
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target

Health Check: How Prudently Does Treace Medical Concepts (NASDAQ:TMCI) Use Debt?

Aug 09
Health Check: How Prudently Does Treace Medical Concepts (NASDAQ:TMCI) Use Debt?

We Discuss Why Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) CEO Compensation May Be Closely Reviewed

May 13
We Discuss Why Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) CEO Compensation May Be Closely Reviewed

Treace Medical Concepts, Inc. (NASDAQ:TMCI) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

May 11
Treace Medical Concepts, Inc. (NASDAQ:TMCI) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Treace Medical Concepts, Inc. Key Details

US$213.8m

Revenue

US$42.5m

Cost of Revenue

US$171.3m

Gross Profit

US$220.4m

Other Expenses

-US$49.2m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.78
Gross Margin
80.12%
Net Profit Margin
-23.01%
Debt/Equity Ratio
55.9%

Treace Medical Concepts, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet and fair value.

1 Risk
1 Reward

About TMCI

Founded
2013
Employees
477
CEO
John Treace
WebsiteView website
www.treace.com

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: 0.3%
  • 3 Months: 8.5%
  • 1 Year: 17.3%
  • Year to Date: 15.0%
In the last week, the market has been flat. Meanwhile, the market is actually up 17% over the past year. Earnings are forecast to grow by 15% annually. Market details ›